Advertisement

Table of contents

  1. Front Matter
    Pages 1-17
  2. Indicaties

    1. Front Matter
      Pages 19-19
    2. H. Folmer, L. W. Draijer
      Pages 21-28
    3. H. Folmer, L. W. Draijer
      Pages 29-37
    4. H. Folmer, L. W. Draijer
      Pages 38-53
    5. H. Folmer, L. W. Draijer
      Pages 54-57
    6. H. Folmer, L. W. Draijer
      Pages 58-90
    7. H. Folmer, L. W. Draijer
      Pages 91-108
    8. H. Folmer, L. W. Draijer
      Pages 109-134
    9. H. Folmer, L. W. Draijer
      Pages 135-150
    10. H. Folmer, L. W. Draijer
      Pages 151-165
    11. H. Folmer, L. W. Draijer
      Pages 166-179
    12. H. Folmer, L. W. Draijer
      Pages 180-252
    13. H. Folmer, L. W. Draijer
      Pages 253-275
    14. H. Folmer, L. W. Draijer
      Pages 276-285
    15. H. Folmer, L. W. Draijer
      Pages 286-292
    16. H. Folmer, L. W. Draijer
      Pages 293-312
    17. H. Folmer, L. W. Draijer
      Pages 313-325
  3. Back Matter
    Pages 327-464

About this book

Editors and affiliations

  • H. Folmer
    • 1
  • L. W. Draijer
    • 1
  1. 1.Afdeling Richtlijnontwikkeling, Sectie FarmacotherapieNHGUtrecht

Bibliographic information